Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Authors
Keywords
Galectin-1, Glioblastoma multiforme, Adjuvant radiotherapy, Radioresistant marker
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-30
DOI
10.1186/s12885-018-4025-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
- (2015) Khaled Messaoudi et al. DRUG DISCOVERY TODAY
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
- (2015) Severa Bunda et al. Nature Communications
- EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
- (2015) Nina Struve et al. Oncotarget
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
- (2014) Rafael Yamashita Ikemori et al. PLoS One
- Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy
- (2014) Pedro R Lowenstein et al. OncoImmunology
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
- (2013) Qi-Wen Fan et al. CANCER CELL
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-1 Is an Independent Prognostic Factor for Local Recurrence and Survival After Definitive Radiation Therapy for Patients With Squamous Cell Carcinoma of the Uterine Cervix
- (2013) Eng-Yen Huang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation
- (2013) Y. Hirota et al. JOURNAL OF RADIATION RESEARCH
- RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
- (2012) Arnab Chakravarti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
- (2012) L Toussaint et al. Molecular Cancer
- A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression
- (2011) Warren P. Mason et al. JOURNAL OF NEURO-ONCOLOGY
- Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
- (2009) Marie Le Mercier et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- K-Ras Nanoclustering Is Subverted by Overexpression of the Scaffold Protein Galectin-3
- (2008) R. Shalom-Feuerstein et al. CANCER RESEARCH
- Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines
- (2008) Tae-Young Jung et al. JOURNAL OF NEUROSURGERY
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started